A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects
Clinical trial NCT00955773 · COMPLETED
Trial details
- NCT number
- NCT00955773
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-17
- Primary completion
- 2011-11-08
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.